Nkarta NKTX
NASDAQ NKTX
$2.59 -0.03 (-1.15%)
As of: Oct 1, 2026 · 10:38 AM EDT

Nkarta (NKTX) Capital Expenditures (2019 - 2026)

Updated

Nkarta's Capital Expenditures was $183,000 in Q2 2026, up 32.6% from $138,000 a year earlier but down 55.7% from the prior quarter.

Analysis

Nkarta (NKTX) Capital Expenditures (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nkarta's Capital Expenditures was $1.15 million through Jun 30, 2026, down 54.7% year-over-year; for FY2025, it was $1.21 million, down 72.6% from FY2024.

  • Capital Expenditures has now declined for three consecutive years, with a five-year compound annual growth rate of -30.6% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $4.41 million in FY2024 (-84.3%), $28.15 million in FY2023 (-40.3%), $47.11 million in FY2022 (+837.5%) and $5.03 million in FY2021 (-33.1%).
  • Quarterly Capital Expenditures has moved between -$8,000 (Q3 2025) and $35.04 million (Q4 2022) over five years.
  • Compared with a year earlier, Capital Expenditures was higher in two of the last seven quarters, with an average decline of 15.2%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q3 2022 (growth of 404.5%); the worst was Q1 2024 (a decline of 96.4%).
  • Per Business Quant data, NKTX's Capital Expenditures in the three quarters before Q2 2026 was $413,000 (Q1 2026), $560,000 (Q4 2025) and -$8,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Nkarta 187.66 Mn 187.66 Mn - 183,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183,000.00
Mar 31, 2026 413,000.00
Dec 31, 2025 560,000.00
Sep 30, 2025 -8,000.00
Jun 30, 2025 138,000.00
Mar 31, 2025 518,000.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 777,000.00
Jun 30, 2024 2.35 Mn
Mar 31, 2024 175,000.00
Dec 31, 2023 6.81 Mn
Sep 30, 2023 6.19 Mn
Jun 30, 2023 10.33 Mn
Mar 31, 2023 4.82 Mn
Dec 31, 2022 35.04 Mn
Sep 30, 2022 7.67 Mn
Jun 30, 2022 2.63 Mn
Mar 31, 2022 1.77 Mn
Dec 31, 2021 1.09 Mn
Sep 30, 2021 1.52 Mn
API Access

Nkarta Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NKTX&period=max&api_key=YOUR_API_KEY